Ifp Advisors, Inc Galectin Therapeutics Inc Transaction History

Ifp Advisors, Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$1.1 - $2.4 $1,100 - $2,400	-1,000 Reduced 33.33%	2,000 $4,000
Q4 2022 Feb 07, 2023	BUY	$1.03 - $1.66 $309 - $498	300 Added 11.11%	3,000 $14,000
Q3 2022 Nov 08, 2022	BUY	$1.31 - $2.48 $262 - $496	200 Added 8.0%	2,700 $13,000
Q2 2022 Sep 06, 2022	BUY	$1.19 - $1.74 $2,975 - $4,350	2,500 New	2,500 $12,000
Q2 2022 Aug 12, 2022	SELL	$1.19 - $1.74 $2,975 - $4,350	-2,500 Closed	0 $0
Q3 2021 Oct 06, 2021	BUY	$2.59 - $4.15 $5,180 - $8,300	2,000 Added 400.0%	2,500 $10,000
Q3 2019 Nov 07, 2019	SELL	$3.0 - $4.05 $11,100 - $14,985	-3,700 Reduced 88.1%	500 $2,000
Q1 2019 May 15, 2019	SELL	$3.86 - $6.02 $13,896 - $21,672	-3,600 Reduced 46.15%	4,200 $21,000
Q4 2018 Jan 23, 2019	SELL	$3.43 - $5.74 $1,557 - $2,605	-454 Reduced 5.5%	7,800 $26,000
Q3 2018 Oct 25, 2018	BUY	$3.68 - $6.93 $10,870 - $20,471	2,954 Added 55.74%	8,254 $0
Q2 2018 Aug 07, 2018	BUY	$3.16 - $9.16 $316 - $916	100 Added 1.92%	5,300 $0
Q4 2017 Jan 24, 2018	SELL	$1.54 - $3.34 $1,232 - $2,672	-800 Reduced 13.33%	5,200 $0
Q4 2016 Jun 03, 2019	SELL	N/A	-700 Reduced 10.45%	6,000 $6,000
Q2 2016 Jun 03, 2019	BUY	N/A	2,500 Added 59.52%	6,700 $10,000
Q1 2016 Jun 03, 2019	BUY	N/A	4,200	4,200 $21,000

10M

1.16M

1.98M

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $73.1M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.